Top US FDA Drug Policy Leader Leaving For White House Detail

White House and FDA building 21
Elizabeth Jungman will take over Grail Sipes' advisory duties in the Center for Drug Evaluation and Research once she moves to the White House. • Source: Nielsen Hobbs; the Pink Sheet | Alamy images
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership